Health-Related Quality of Life (HRQoL) Assessments in Research on Patients with Adult Rare Solid Cancers: A State-of-the-Art Review
Authors:
- Catarina S. PadillaCPCatarina S. Padilla
- Cristiane D. BergerotCBCristiane D. Bergerot
- Kim DijkeKDKim Dijke
- Evelyne RoetsEREvelyne Roets
- Gabriela BokováGBGabriela Boková
- Veronika InnerhoferVIVeronika Innerhofer
- Samantha C. SodergrenSSSamantha C. Sodergren
- Rosanna MancariRMRosanna Mancari
- Cristiana BergaminiCBCristiana Bergamini
- Kirsty M. WayKWKirsty M. Way
- Olga SapoznikovOSOlga Sapoznikov
- Jacobus A. BurgersJBJacobus A. Burgers
Open Access
Abstract
Background: Health-related quality of life (HRQoL) is an important patient-reported outcome for all cancer patients, including adult patients with rare solid cancers. However, current knowledge of HRQoL in this population is limited, which hinders the delivery of personalized care. This review aimed to explore the heterogeneity of HRQoL among adult patients with a solid rare cancer across the ten European Reference Network for Rare Adult Solid Cancers (EURACAN) domains and to summarize the HRQoL measures used in clinical research. Methods: A systematic literature search was conducted to identify all clinical studies assessing HRQoL in adult patients with a solid rare cancer. Four databases (MEDLINE, PubMed, PsycINFO, and Web of Science/Scopus) were searched (February 2023). Results: The search yielded 18,704 articles, of which 1416 articles were fully screened and 463 were eligible for analysis. Of these, 397 studies used generic tools to assess HRQoL, while 270 used tumor-specific instruments. Three EURACAN domains (sarcoma, endocrine tumors, and thoracic tumors) primarily assessed HRQoL using generic questionnaires. Additionally, the rare gynecological tumor, rare male genitourinary, and sarcoma EURACAN domains lacked specific HRQoL measures. Brain, head and neck, and uveal melanoma EURACAN domains used tumor- or domain-specific questionnaires in more than half of the studies. Conclusions: This state-of-the-art literature review shows that HRQoL assessment is gradually becoming more prevalent in adult solid rare cancer research. A combination of generic, tumor-specific, and domain-specific questionnaires across various rare cancer domains has proven effective in capturing a broad range of HRQoL issues. However, many EURACAN domains still lack specific strategies for assessing HRQoL, which limits the ability to fully understand and address patients’ experiences. Future research should prioritize developing comprehensive and robust HRQoL measurement strategies and tools to enable meaningful clinical research and to ensure that the patient voice is incorporated in their clinical care.Keywords
Funding Information
- the European Organisation for Research and Treatment of Cancer Quality of Life Group (003-2022)
This publication has 114 references indexed in Scilit:
- Body image, self-esteem, and quality of life in patients with primary malignant bone tumorsArchives of orthopaedic and trauma surgery, 2019
- Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical TreatmentJAMA Otolaryngology–Head & Neck Surgery, 2019
- Assessment of distress and quality of life in rare cancersPsycho-Oncology, 2018
- Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2017
- Sinonasal quality of life after endoscopic resection of malignant sinonasal and skull base tumorsThe Laryngoscope, 2017
- Health-related quality of life following treatment for extremity soft tissue sarcomaJournal of Surgical Oncology, 2016
- Long‐term changes in quality of life after endoscopic resection of sinonasal and skull‐base tumorsInternational Forum of Allergy & Rhinology, 2015
- Chronic adverse events and quality of life after radiochemotherapy in anal cancer patientsStrahlentherapie und Onkologie, 2013
- Psychological aspects affect quality of life in patients with oral squamous cell carcinomasPsycho-Oncology, 2012
- Quality of Life Outcomes in Patients with Anal Cancer after Combined RadiochemotherapyStrahlentherapie und Onkologie, 2011